Loading...

LungLife AI, Inc.

LLAI.L•LSE
Healthcare
Medical - Diagnostics & Research
£4.15
£-0.10(-2.35%)

LungLife AI, Inc. (LLAI.L) Company Profile & Overview

Explore LungLife AI, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

LungLife AI, Inc. (LLAI.L) Company Profile & Overview

LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOPaul Pagano

Contact Information

https://www.lunglifeai.com
805-409-9868
2545 West Hillcrest Drive, Thousand Oaks, CA, 91320

Company Facts

8 Employees
IPO DateJul 8, 2021
CountryUS

Frequently Asked Questions

;